Convergen Secures $15 Million in Seed+ Round, Total Funding Reaches $25 Million for Innovative Protein Degradation Platform Convergen has successfully
Category: Funding
Seattle Biotech Secures $35 Million for Hepatitis D Treatment under Leen Kawas
EIT Pharma Secures $35 Million Series A Round to Propel Lonafarnib Towards FDA Approval
Regulus Therapeutics: Navigating the MicroRNA Therapeutics Landscape
The Hidden Costs of the U.S.-Canada Trade Disruption
Quality Control CEO Pierre ‘P’ Thomas Hospitalized Following Medical Emergency
Scottish Government Invests in Biomanufacturing Scale-Up Initiatives
Capital Discipline in Biotech: Navigating Tight Margins for Sustainable Growth
Indian Pharma Shifts Towards Innovative Therapeutics
India’s pharmaceutical sector is undergoing a significant transformation, moving beyond its established reputation as the “pharmacy of the world” to
Top 5 US Stocks at Their 52-Week Highs Worth Considering
Addressing the Rise of Mental Health Disorders in the U.S.
Johnson & Johnson’s Journey Through the National Priority Voucher Program
Singapore Startup Secures $1.2 Million for Innovative Health Monitoring Technology
UMS Denies Unauthorized Conference Claims
Navigating the Future: Tango Therapeutics’ Leadership Strategy in Oncology
Exposing Collusion in the Meat Industry: The Agri Stats Case
American families have faced significant challenges at the meat counter, and recent findings from the Department of Justice Antitrust Division (DOJ)





























































































